Revolution Medicines is a clinical-stage pharma company with a market cap of ~6 billion. Click here to find out why RVMD ...

We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at ...

Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) hit a new 52-week low during mid-day trading on Saturday . The stock traded as low as $30.94 and last traded at $31.32, with a volume of ...

Quantbot Technologies LP bought a new position in shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) during the ...

To listen to a live webcast of any of these events, or access archived webcasts, please visit: https://ir.revmed.com/events-and-presentations. Following the live webcasts, replays will be available on ...

Stifel analyst Benjamin Burnett lowered the firm’s price target on Revolution Medicines (RVMD) to $64 from $78 and keeps a Buy rating on the ...

REDWOOD CITY, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS ...

The chairs of the BMJ Commission on the Future of Academic Medicine set out principles for transforming academic medicine and to help improve population and planetary health Academic medicine is in ...

About Revolution Medicines, Inc. Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D ...

We recently compiled a list of the 10 Best Debt Free Mid Cap Stocks to Buy Now. In this article, we are going to take a look at where Revolution Medicines, Inc.